0001594864-17-000036.txt : 20171005 0001594864-17-000036.hdr.sgml : 20171005 20171005170225 ACCESSION NUMBER: 0001594864-17-000036 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20171005 DATE AS OF CHANGE: 20171005 EFFECTIVENESS DATE: 20171005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296114 FILM NUMBER: 171125166 BUSINESS ADDRESS: STREET 1: 400 DEXTER AVENUE NORTH, SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2065821600 MAIL ADDRESS: STREET 1: 400 DEXTER AVENUE NORTH, SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001594864 Juno Therapeutics, Inc. 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA WASHINGTON 98109 2065821600 DELAWARE FC Therapeutics, Inc. None Corporation true 2013 Hans Bishop 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Steven Harr 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Executive Officer Robert Azelby 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Executive Officer Sunil Agarwal 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Executive Officer Bernard J. Cassidy 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Executive Officer Hal Barron 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Anthony Evnin 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Richard Klausner 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Promoter Robert Nelsen 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Promoter Howard Pien 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Jay Flatley 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Mary Agnes Wilderotter 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Thomas Daniel 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Rupert Vessey 400 DEXTER AVENUE NORTH, SUITE 1200 Seattle WA WASHINGTON 98109 Director Biotechnology $25,000,001 - $100,000,000 06c false 2017-09-26 false true false 0 31091407 31091407 0 See the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 22, 2017. false 1 0 0 0 false Juno Therapeutics, Inc. /s/ Bernard J. Cassidy Bernard J. Cassidy General Counsel & Secretary 2017-10-05